PembroRT

Albert Einstein College of Medicine · Phase 2 active Small molecule

At a glance

Generic name	PembroRT
Sponsor	Albert Einstein College of Medicine
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PembroRT CI brief — competitive landscape report
PembroRT updates RSS · CI watch RSS
Albert Einstein College of Medicine portfolio CI